Evidence map›Paper›PMID 37265827›Full record

ArticleMalawi medical journal : the journal of Medical Association of Malawi2022

A Malawian pharmaceutical response to the COVID-19 Pandemic.

Baxter Kachingwe, Peter Kumpalume, Felix Khuluza, Kumbukani Nyirenda, Ernest Matambo, John Mponda, Nettie Dzabala, Francis Chiumia, Ibrahim Chikowe, Frider Chimimba and 4 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Malawi medical journal : the journal of Medical Association of Malawi, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Baxter KachingweKamuzu University of Health Sciences's Department of Pharmacy, Blantyre, Malawi.
Peter KumpalumeKamuzu University of Health Sciences's Department of Pharmacy, Blantyre, Malawi.
Felix KhuluzaKamuzu University of Health Sciences's Department of Pharmacy, Blantyre, Malawi.
Kumbukani NyirendaKamuzu University of Health Sciences's Department of Pharmacy, Blantyre, Malawi.
Ernest MatamboKamuzu University of Health Sciences's Department of Pharmacy, Blantyre, Malawi.
John MpondaKamuzu University of Health Sciences's Department of Pharmacy, Blantyre, Malawi.
Nettie DzabalaKamuzu University of Health Sciences's Department of Pharmacy, Blantyre, Malawi.
Francis ChiumiaKamuzu University of Health Sciences's Department of Pharmacy, Blantyre, Malawi.
Ibrahim ChikoweKamuzu University of Health Sciences's Department of Pharmacy, Blantyre, Malawi.
Frider ChimimbaKamuzu University of Health Sciences's Department of Pharmacy, Blantyre, Malawi.
Nelson NyolokaKamuzu University of Health Sciences's Department of Pharmacy, Blantyre, Malawi.
Louisa AlfazemaKamuzu University of Health Sciences's Department of Pharmacy, Blantyre, Malawi.
Happy NyirongoKamuzu University of Health Sciences's Department of Pharmacy, Blantyre, Malawi.
Dallas SmithKamuzu University of Health Sciences's Department of Pharmacy, Blantyre, Malawi.
University of Malawi · MWBlantyre Institute for Community Ophthalmology · MWKamuzu University of Health SciencesKamuzu Central Hospital · MW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has elicited swift and innovative responses due to the severity of the outbreak. Higher education institutions worldwide with pharmacy programs have identified vital gaps in COVID-19 care and has undertaken proactive steps to aid in the fight against the coronavirus. In Malawi, the Kamuzu University of Health Science's Department of Pharmacy initiated the production of a modified formulation of the World Health Organization's (WHO) recommended hand sanitizer. This manufacturing venture involved mobilizing the pharmacy faculty, identifying gaps in supplies and equipment, and utilizing evidenced-based information to create a high-quality sanitation product, which passed the requirements as tested by the Malawi Bureau of Standards. The department of pharmacy is expanding their distribution of the product to meet the needs of frontline healthcare workers and vulnerable populations. With historical issues of accessing care in Malawi and with COVID-19's spread among healthcare workers, this hand sanitizer venture is vital in the public healthcare's system response. The department of pharmacy will continue to lead the pharmacy profession in Malawi to provide targeted interventions in this unprecedented time.

Indexed as

COVID-19Hand SanitizersPharmacyHumansPandemicsPharmaceutical PreparationsHand SanitizersPharmaceutical PreparationsAcademiaCapacity BuildingCOVID-19Hand SanitizerMalawiPharmaceutical PreparationsPharmaceutical Services

Identifiers

PMID37265827
PMCPMC10230587
OpenAlexW4223501244

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.